Ambler company Moberg ICU solutions recently received a 3 million dollar investment from Micromed SAS (subsidiary of ArchiMed, a European equity fund) to support product sales and innovation in the precision management of patients with brain injuries in critical care.

Moberg ICU Solutions develops and manufactures patient monitoring solutions for acute care. Their products are sold throughout the United States, Canada and Europe. Founded in 1998, they continue to develop products vital in neurocritical care.

From PR Newswire:

Moberg’s Component Neuromonitoring System (CNS) works together with the vital signs monitor and other medical devices to provide a comprehensive view of brain dynamics promoting timely intervention by caregivers. The product is unique in that it is also a full-function continuous EEG machine and is the first medical device that can show the relationships between the electrical activity of the brain and other physiology at the bedside.

Moberg Research Inc. (dba Moberg ICU Solutions) is located at 224 W. Maple Street in Ambler.